BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng Q, Jiang J, Huo Y, Chen D. Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes. Cardiovasc Diabetol 2019;18:131. [PMID: 31594547 DOI: 10.1186/s12933-019-0930-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Perumalsamy S, Wan Ahmad WA, Zaman Huri H. Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes? Healthcare (Basel) 2021;9:623. [PMID: 34071097 DOI: 10.3390/healthcare9060623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ram E, Sternik L, Klempfner R, Iakobishvili Z, Fisman EZ, Tenenbaum A, Zuroff E, Peled Y, Raanani E. Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery. Cardiovasc Diabetol. 2020;19:86. [PMID: 32534591 DOI: 10.1186/s12933-020-01069-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zaidi NR, Gilani SA, Mehboob R, Waseem H, Hassan A. Diagnostic accuracy of carotid intima media thickness by B-mode ultrasonography in coronary artery disease patients. Arch Med Sci Atheroscler Dis 2020;5:e79-84. [PMID: 32529110 DOI: 10.5114/amsad.2020.95651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sobczak AIS, Stewart AJ. Coagulatory Defects in Type-1 and Type-2 Diabetes. Int J Mol Sci 2019;20:E6345. [PMID: 31888259 DOI: 10.3390/ijms20246345] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
5 Janjusevic M, Fluca AL, Gagno G, Pierri A, Padoan L, Sorrentino A, Beltrami AP, Sinagra G, Aleksova A. Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis. Int J Mol Sci 2022;23:2336. [PMID: 35216451 DOI: 10.3390/ijms23042336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lu T, Forgetta V, Yu OHY, Mokry L, Gregory M, Thanassoulis G, Greenwood CMT, Richards JB. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes. Cardiovasc Diabetol 2020;19:12. [PMID: 32000781 DOI: 10.1186/s12933-020-0988-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Huth C, Bauer A, Zierer A, Sudduth-Klinger J, Meisinger C, Roden M, Peters A, Koenig W, Herder C, Thorand B. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study. Cardiovasc Diabetol 2020;19:32. [PMID: 32164753 DOI: 10.1186/s12933-020-01003-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Song Y, Choi JE, Kwon YJ, Chang HJ, Kim JO, Park DH, Park JM, Kim SJ, Lee JW, Hong KW. Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. J Transl Med 2021;19:85. [PMID: 33632238 DOI: 10.1186/s12967-021-02751-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]